The lysosomal system in neurons. Involvement at multiple stages of Alzheimer's disease pathogenesis - PubMed (original) (raw)
The lysosomal system in neurons. Involvement at multiple stages of Alzheimer's disease pathogenesis
R A Nixon et al. Ann N Y Acad Sci. 1992.
Abstract
Disturbed lysosomal function may be implicated at several stages of Alzheimer's pathogenesis. Lysosomes and acid hydrolases accumulate in the majority of neocortical pyramidal neurons before typical degenerative changes can be detected, indicating that altered lysosome function is among the earliest markers of metabolic dysfunction in Alzheimer's disease. These early alterations could reflect accelerated membrane and protein turnover, defective lysosome or hydrolase function, abnormal lysosomal trafficking or any combination of these possibilities. Because APP is partly metabolized in lysosomes, early disturbances in lysosomal function could promote the production of abnormal and/or neurotoxic APP fragments within intact cells. Lysosomal abnormalities progressively worsen as neurons begin to degenerate. Based on existing literature on cell death, increased perturbation and instability of the lysosomal system may be expected to contribute to the atrophy and eventual lysis of the neuron. Finally, the release of hydrolase-filled lysosomes and lipofuscin aggregates from dying neurons accounts for the abundant deposition of enzymatically active acid hydrolases of all classes in the extracellular space--a phenomenon that may be unique to Alzheimer's disease. Acting on APP present in surrounding dystrophic neurites, cellular debris and astrocyte processes, dysregulated hydrolases may cleave APP in atypical sequential patterns, thereby generating self-aggregating protease-resistant APP fragments that can be only processed to beta-amyloid. Genetic mutations or posttranslational factors of APP should further enhance the generation of amyloidogenic fragments by a dysregulated lysosomal system. Given that very little, if any, beta-amyloid is detected intracellularly, yet extracellular beta-amyloid is very abundant, our data suggest that the final steps of APP processing and the generation of most beta-amyloid in the brain parenchyma occur extracellularly and may involve one or more lysosomal proteases.
Similar articles
- Lysosomal abnormalities in degenerating neurons link neuronal compromise to senile plaque development in Alzheimer disease.
Cataldo AM, Hamilton DJ, Nixon RA. Cataldo AM, et al. Brain Res. 1994 Mar 21;640(1-2):68-80. doi: 10.1016/0006-8993(94)91858-9. Brain Res. 1994. PMID: 8004466 - Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease.
Cataldo AM, Paskevich PA, Kominami E, Nixon RA. Cataldo AM, et al. Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):10998-1002. doi: 10.1073/pnas.88.24.10998. Proc Natl Acad Sci U S A. 1991. PMID: 1837142 Free PMC article. - The Role of Lysosomes in a Broad Disease-Modifying Approach Evaluated across Transgenic Mouse Models of Alzheimer's Disease and Parkinson's Disease and Models of Mild Cognitive Impairment.
Hwang J, Estick CM, Ikonne US, Butler D, Pait MC, Elliott LH, Ruiz S, Smith K, Rentschler KM, Mundell C, Almeida MF, Stumbling Bear N, Locklear JP, Abumohsen Y, Ivey CM, Farizatto KLG, Bahr BA. Hwang J, et al. Int J Mol Sci. 2019 Sep 9;20(18):4432. doi: 10.3390/ijms20184432. Int J Mol Sci. 2019. PMID: 31505809 Free PMC article. - Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer's disease.
Glabe C. Glabe C. J Mol Neurosci. 2001 Oct;17(2):137-45. doi: 10.1385/JMN:17:2:137. J Mol Neurosci. 2001. PMID: 11816787 Review. - Alzheimer's disease.
De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV. De-Paula VJ, et al. Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Subcell Biochem. 2012. PMID: 23225010 Review.
Cited by
- Hydrogen peroxide induces lysosomal protease alterations in PC12 cells.
Lee DC, Mason CW, Goodman CB, Holder MS, Kirksey OW, Womble TA, Severs WB, Palm DE. Lee DC, et al. Neurochem Res. 2007 Sep;32(9):1499-510. doi: 10.1007/s11064-007-9338-5. Epub 2007 Apr 18. Neurochem Res. 2007. PMID: 17440810 - Lack of human-like extracellular sortilin neuropathology in transgenic Alzheimer's disease model mice and macaques.
Zhou FQ, Jiang J, Griffith CM, Patrylo PR, Cai H, Chu Y, Yan XX. Zhou FQ, et al. Alzheimers Res Ther. 2018 Apr 24;10(1):40. doi: 10.1186/s13195-018-0370-2. Alzheimers Res Ther. 2018. PMID: 29690919 Free PMC article. - Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations.
Cataldo AM, Peterhoff CM, Troncoso JC, Gomez-Isla T, Hyman BT, Nixon RA. Cataldo AM, et al. Am J Pathol. 2000 Jul;157(1):277-86. doi: 10.1016/s0002-9440(10)64538-5. Am J Pathol. 2000. PMID: 10880397 Free PMC article. - Genetic Overlap Between Alzheimer's Disease and Depression Mapped Onto the Brain.
Monereo-Sánchez J, Schram MT, Frei O, O'Connell K, Shadrin AA, Smeland OB, Westlye LT, Andreassen OA, Kaufmann T, Linden DEJ, van der Meer D. Monereo-Sánchez J, et al. Front Neurosci. 2021 Jul 5;15:653130. doi: 10.3389/fnins.2021.653130. eCollection 2021. Front Neurosci. 2021. PMID: 34290577 Free PMC article. - Tau function and dysfunction in neurons: its role in neurodegenerative disorders.
Avila J, Lim F, Moreno F, Belmonte C, Cuello AC. Avila J, et al. Mol Neurobiol. 2002 Jun;25(3):213-31. doi: 10.1385/MN:25:3:213. Mol Neurobiol. 2002. PMID: 12109872 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical